NEUROSTIMULATION TREATMENT FOR OVERACTIVE BLADDER: AN EVALUATION OF COST EFFECTIVENESS DATA

被引:0
|
作者
MacDiarmid, Scott
Martinson, Melissa
Black, Edward
机构
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:112 / 112
页数:1
相关论文
共 50 条
  • [1] NEUROSTIMULATION TREATMENT FOR OVERACTIVE BLADDER: AN EVALUATION OF COST EFFECTIVENESS DATA
    MacDiarmid, Scott
    Martinson, Melissa
    Black, Edward
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E478 - E478
  • [2] COST EFFECTIVENESS OF SACRAL NEUROSTIMULATION FOR OVERACTIVE BLADDER IN MEXICO
    Soto, H.
    Sanchez, K.
    Escobar Juarez, Y.
    Constanzo, A.
    Ceballos, R.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A45 - A45
  • [3] COST-EFFECTIVENESS OF PHARMACOLOGIC TREATMENT OF OVERACTIVE BLADDER
    Malone, D. C.
    Armstrong, E. P.
    Bui, C.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A155 - A155
  • [4] Optimizing quality of care and cost effectiveness in the treatment of overactive bladder
    不详
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2001, 7 (02): : S43 - S45
  • [5] COST EFFECTIVENESS OF VIBEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER IN THE UNITED STATES
    Chen, J., V
    Klein, T. M.
    Mudd, P.
    [J]. VALUE IN HEALTH, 2021, 24 : S235 - S235
  • [6] COST EFFECTIVENESS OF OVERACTIVE BLADDER TREATMENT WITH MIRABEGRON IN PATIENTS IN SOUTH KOREA
    Suh, D.
    Lee, S.
    Lim, S. J.
    Song, J.
    Ko, G.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A847 - A847
  • [7] Peripheral tibial neurostimulation versus Tolterodine in treatment of overactive bladder
    Preyer, O.
    Boris, G.
    Laml, T.
    Umek, W.
    Zehetmayer, S.
    Hanzal, E.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (05) : 517 - 517
  • [8] The cost effectiveness of mirabegron for the treatment of overactive bladder: three US perspectives
    Wielage, R. C.
    Perk, S.
    Campbell, N. L.
    Ng, D.
    Klein, T. M.
    Posta, L. M.
    Yuran, T.
    Klein, R. W.
    Perkins, A.
    Berner, T.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S67 - S67
  • [9] Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States
    Chen, Jing Voon
    Klein, Timothy M.
    Nesheim, Jeffrey
    Mudd, Paul N., Jr.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 1092 - 1100
  • [10] Cost effectiveness and quality of life considerations in the treatment of patients with overactive bladder
    McGhan, WF
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2001, 7 (02): : S62 - S75